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Depression increases in patients with
Parkinson’s disease according to the
increasing severity of the cognitive impairment
Em pacientes com doença de Parkinson, a depressão aumenta de acordo com o aumento
da gravidade do comprometimento cognitivo
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ABSTRACT
Objective: To test the hypothesis that severity of cognitive impairment modifies the association between depression and Parkinson’s
disease (PD). Method: One-phase population-based door-to-door surveys. This is a secondary analysis of 1,451 people aged 65 years and
older with cognitive impairment living in defined catchment areas. Depression was estimated according to ICD-10, self-reported PD,
disability according to WHODAS-II and cognitive status according to the CSI-D. Results: The mean age of the sample was 79.3 years old and
most (69%) were women. Of the total sample,16.1% had depression and it was significantly higher among participants with PD. There was
an increase on the ORs of the association between depression and PD with decreased scores in the cognitive test (Adjusted OR from 0.98
to 8.04). Conclusion: The association between depression and PD increases with the severity of the cognitive impairment.
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RESUMO
Objetivo: Testar a hipótese que a gravidade do prejuízo cognitivo modifica a associação entre depressão e doença de Parkinson (DP).
Método: Estudo populacional através da análise secundária de 1.451 pessoas com idade maior ou igual a 65 anos com prejuízo cognitivo
que residiam em áreas de abrangência definidas. A depressão foi estimada de acordo com a CID-10, auto-relato de DP, incapacidade
conforme a WHODAS-II e nível cognitvo de acordo com a CSI-D. Resultado: A média de idade foi 79,3 anos, predominaram as mulheres
(69%). Do total de indivíduos, 16,1% tinham depressão, significantemente maior entre os participantes com DP. Houve aumento gradativo
na OR relativa à associação entre depressão e DP com a diminuição do escore no teste cognitivo (OR ajustado variou de 0,98 a 8,04).
Conclusão: A associação entre depressão e DP parece aumentar com a gravidade do prejuízo cognitivo.
Palavras-chave: parkinsonismo, depressão, prejuízo cognitivo, doença de Parkinson.
Depression and dementia are common non-motor man-
ifestations of Parkinson’s disease (PD). Prevalence estimates
vary widely, but most studies have suggested that 40% to
50% of PD patients present clinically relevant depression1, 2
and 30% of them present dementia3.
Cognitive impairment itself increases the risk of depres-
sion4 and thus it is plausible that the presence of cognitive
impairment might influence the association of depression
with PD. Most studies investigating the association of depres-
sion and PD are based on convenience clinical samples and
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frequently exclude patients with dementia or cognitive
impairment5,6. Although both cognitive impairment and
depression are frequent comorbidities of PD, little is known
on how the association of depression and PD varies accord-
ing to cognitive impairment.
We estimated the association between depression and
PD in a large community sample of 1,451 elderly with cognit-
ive impairment and tested the hypothesis that the strength
of the association between depression and PD increases by
severity of cognitive impairment even after adjusting for dis-
ability, a potential mediator of this association.
METHOD
This study is a secondary analysis of the 10/66 Dementia
Research Group population-based surveys. Further details
on the protocol can be found elsewhere7.
Participants were recruited following informed signed
consent. Studies were approved by local ethical committees
as well as by the ethical committee at King’s College London.
Setting and sample: All residents aged 65 years and older
from 11 geographically defined catchment areas in India,
China, Cuba, Dominican Republic, Venezuela, Mexico, and
Peru were interviewed (n=14,960) in one-phase population-
based cross-sectional door-to-door surveys. The analysis pre-
sented in this study is restricted to those with cognitive
impairment (n=1,451). Response rates were 80% and above
in all sites. The same protocol was used in all countries
allowing fair comparisons between sites.
Measurements
Parkinson’s disease: participants and their informants
were asked if a doctor had ever diagnosed the participant
with PD. Possible answers were: No, probable or certain.
Only those who answered “certainly yes” were considered
as “self-reported PD”.
Diagnosis of depression: In order to categorize depressed
participants, International Classification of Diseases 10th
revision (ICD-10) criteria8 were used. The ICD–10 divides
depressive episodes into mild, moderate and severe, for this
analyse we considered any current ICD-10 depressive epis-
ode, irrespectively of the severity. These were derived using
a computerized algorithm applied to the geriatric mental
state (GMS)9,10.
Cognitive impairment: the cognitive assessment was
based on the “Community Screening Instrument for
Dementia” (CSI-D), a 32 items cognitive test assessing nam-
ing, comprehension, memory, orientation, apraxia and con-
structional difficulty. It has shown very good psychometric
properties for cross-cultural studies11,12. The CSI-D popu-
lation normative data for Latin America, India and China
for the 10/66 Dementia Research Group has been previously
detailed described elsewhere13. Objective impairment was
defined as a score 2 standard deviations (SDs) below the
average obtained with the total sample (n=14,960) and was
used to select the sample included in this analysis.
Dementia was determined according to the DSM-IV and/
or 10/66 dementia diagnosis14.
Disability: It was measured using the 12-item interviewer-
administered World Health Organization Disability
Assessment Schedule II (WHODAS-II)15, developed by
World Health Organization as a culture-fair assessment to
use in cross-cultural studies.
Sociodemographic status: Age of all participants was
established from participant and informant report and an
official ID document; when the information was not clear
or there was a discrepancy, an event calendar was used.
Level of education and gender were also recorded during
the interview.
Statistical analysis
We described the participants’ characteristics in partici-
pants with and without PD and estimated the association
between depression and PD adjusted for socio-demographic
characteristic and disability. Odds ratios (OR) are derived
from logistic regression models with 95% confidence inter-
vals (95% confidence interval (CI)). To explore how the asso-
ciation between depression and PD behaved according to
levels of cognition we used the same model as before for
each levels of cognitive impairment according to quartiles
of scores on the CSI-D. In order to further understand
how cognition affects the association between depression
and Parkinson we repeat the same logistic regression models
among people with and we have also conducted the same
analysis among participants with and without dementia.
RESULTS
A total of 1,451 participants were classified as having cog-
nitive impairment and were included in this analysis. The
sample mean age was 79.3 (standard deviation (SD) 0.2)
years old and most part of participants were women
(69%). Overall, educational levels were low and 61.1% did
not complete primary school. Levels of disability were high,
38.3% of the whole sample and 54.8% of PD patients
reported 15 or more days loss due to disability in the
last month. Table 1 shows participants’ characteristics
according to the presence of PD. Groups with and without
PD did not significantly differed regarding their mean age,
gender, mean scores on cognitive tests and levels of edu-
cation, but PD patients had much higher levels of disability.
A total of 234 (16.1%) individuals fulfilled criteria for
depressive episode according to ICD-10 and 42 (2.9%)
reported having PD.
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Depression was significantly more frequent among parti-
cipants with PD, 28.5% (12) versus non-PD subjects 15.8%
(222). Crude OR was 2.18 (95%CI 1.10-4.32) and after adjust-
ing for age, gender, disability and years of education the
association of PD with depression remained significant
(OR 2.19, 95%CI 1.08-4.45).
Table 2 shows the association of PD and depression by
quartiles of cognitive status (crude and adjusted for age, gen-
der, level of education and functional disability). When
divided by quartiles of cognitive status, PD was significantly
associated with depression only among those most severely
impaired (adjusted OR 8.04 95%CI 1.57-41.15). There was a
clear increase in the OR values with the decrease in cognitive
test scores ( from 8.04 among the most impaired to 0.98 to
the least impaired). We have also looked this association
among participants with and participants without dementia,
which shows a much stronger association between depres-
sion and PD among people with dementia (adjusted
OR=4.44, 95%CI 1.80-10.93) than among people with cognit-
ive impairment but without dementia (adjusted OR=0.69,
95%CI 0.18-2.55).
DISCUSSION
We studied the relationship between PD and depres-
sion in a community sample of 1,451 elderly subjects with
cognitive impairment from seven different low and middle-
income countries. We found a strong association between
depression and PD, which was stronger among those with
worse cognitive impairment and among those with dementia
In our sample around one third of those with PD were
depressed. There was a strong positive association of PD
and depression even after adjusting for age, gender, levels
of education and disability. In a recent systematic review,
Reijnders et al. (2008)2 found that estimates on the preval-
ence of depression in PD vary according to study methodo-
logy, being lower in community based compared to clinical
samples. These authors found a mean prevalence of 8.1%
for studies assessing major depression in PD patients from
the general population. We used a structured interview in
a community sample of cognitive impaired elderly and found
a much higher prevalence (28.5%), which could be explained
by the fact that we had a cognitively impaired sample and
we used ICD-10 for diagnosing depressive episode.
Small previous studies suggested that the association
of depression and PD is stronger for those with cognitive
impairment16,17,18, but none looked at this association
according to the severity of the cognitive impairment in
a community sample. When we divided our sample by
quartiles of levels of cognitive impairment we found that
the association of depression with PD increased with
increased cognitive impairment. Cognitive impairment
itself increases the risk for depression irrespectively of other
Table 1. Demographics and clinical characteristics of participants according to PD status.
With PD Without PD Total
N=42 N=1,409 N=1,451
Mean age (SD) 78.5 (1.15) 79.4 (0.21) 79.3 (0.20)
Female N (%) 26 (61.9) 975 (69.2) 1,001 (69.0)
Education N (%)
None or incomplete primary 18 (42.9) 855 (61.6) 873 (61.1)
Complete primary 17 (40.5) 328 (23.6) 345 (24.1)
Complete secondary 4 (9.5) 132 (9.5) 136 (9.5)
Complete tertiary 3 (7.1) 73 (5.3) 76 (5.3)
CSI-D mean scores (SD) 23.2 (1.08) 21.0 (0.22) 21.4 (0.22)
WHODAS-II mean scores (SD) 54.0 (4.14) 38.0 (0.81) 38.5 (0.80)
15 or more disability days N (%) 23 (54.8) 533 (37.8) 556 (38.3)
Depression N (%) 12 (28.5) 222 (15.8) 234 (16.1)
Dementia N (%) 24 (57.1) 928 (64.8) 952 (64.6)
SD: standard deviation; CSI-D: Community Screening Instrument for Dementia; WHODAS-II: World Health Organization Disability Assessment Schedule II.
Table 2. Association of PD with depression according to levels of cognitive impairments and dementia status.
Impairment (by Quartiles)
(OR) Multi-variable* adjusted OR
OR (95% CI) OR (95% CI)
Most impaired (1st quartile) 5.40 (1.24-23.54) 8.04 (1.57–41.15)
Intermediate Impaired (2nd quartile) 2.77 (0.65-11.90) 2.14 (0.45–10.26)
Less impaired (3rd quartile) 1.61 (0.42-6.12) 1.42 (0.33–6.15)
Least impaired (4th quartile) 1.32 (0.36-4.87) 0.98 (0.24–4.02)
With Dementia 3.78 (1.62-8.83) 4.44 (1.80-10.93)
Without Dementia 0.86 (0.24-3.03) 0.69 (0.18-2.55)
OR: odds ratio; *adjusted by age, gender, level of education and functional disability.
428 Arq Neuropsiquiatr 2014;72(6):426-429
diseases4. It might be that either depression or cognitive
decline are symptoms of a more severe presentation of
PD or that the presence of depression leads to cogni-
tive deterioration.
PD is the second most common neurodegenerative disor-
ders after Alzheimer disease. Nevertheless overall, PD is a
low prevalent condition and only few studies are based in
community samples. One strength point of our study is that
we used data from community-based surveys in seven coun-
tries. However, yet our sample included only 42 participants
with PD, which brings some uncertainty to our estimates.
Another limitation to be considered is that we used self-
report to identify participants with PD, the same protocol
was used in all sites. Also, diagnosis of PD is difficult to be
ascertained and misdiagnosis is common even among
specialists19. Self-reported PD has been validated against
post mortem neuropathological examination in a large
prospective community based study20, showing that self-
reported PD is a good predictor of PD. Moreover the preval-
ence of PD we found is very similar to PD prevalence among
other populations of older adults.
The cognitive deficits found in PD depressed patients can
be reversible with remission of depressive symptoms21, how-
ever large prospective studies are needed to test if treating
depression in PD would reduce the likelihood of developing
dementia. Our findings show that the strength of the asso-
ciation of depression with PD increases with the severity
of cognitive impairment and is also stronger among people
with dementia. It is difficult to disentangle how much of this
association is due to the bad performance of people with
depression in the cognitive tests, however it is still plausible
to think that the prevalence of depression among people
with PD might be underestimated if people with impaired
cognition or dementia are excluded.
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